Characteristics | Infiltration groupa | Non-infiltration groupb | P-value |
---|---|---|---|
n = 12 | n = 28 | ||
Age, median (range) (years) | 69 (61–82) | 66.5 (40–84) | 0.585c |
Gender, n (%)/n (%) (male/female) | 5 (41.7%) /7 (58.3%) | 18 (64.3%) /10 (35.7%) | 0.185d |
Digestive symptoms, n (%)/n (%) (+/−) | 6 (50.0%) /6 (50.0%) | 5 (17.9%) /23 (82.1%) | 0.037d |
Clinical subtypes of ATLL, n (%)/n (%)/n (%)/n (%) (acute/lymphoma/chronic/smoldering) | 9 (75.0%) /3 (25.0%) /0 (0%) /0 (0%) | 14 (50.0%) /3 (10.7%) /5 (17.8%) /6 (21.4%) | 0.080d |
Superficial lymphadenopathy, n (%)/n (%) (+/−) | 7 (58.3%) /5 (41.7%) | 19 (67.9%) /9 (32.1%) | 0.563d |
Hepatosplenomegaly, n (%)/n (%) (+/−) | 6 (50.0%) /6 (50.0%) | 11 (39.3%) /17 (60.7%) | 0.530d |
Skin lesions, n (%)/n (%) (+/−) | 4 (33.3%) /8 (66.7%) | 22 (78.6%) /6 (21.4%) | 0.006d |
Opportunistic infections, n (%)/n (%) (+/−) | 4 (33.3%) /8 (66.7%) | 11 (39.3%) /17 (60.7%) | 0.722d |